Vitronectin for Mouse Bone Marrow Cells
11/30/23
Publication Title:
Tm4sf19 Deficiency Inhibits Osteoclast Multinucleation and Prevents Bone Loss
Advanced BioMatrix Products Used:
How the products were used:
Vitronectin was used as a coating for culturing and preparing mouse bone marrow cells. The researchers investigated the effect of Tm4sf19 deficiency on osteoclast differentiation.
Article Conclusion:
We suggest that Tm4sf19 regulates osteoclast function and that LEL-Fc may be a promising drug to target bone destructive diseases caused by osteoclast hyper-differentiation.
Link to the publication:
https://www.sciencedirect.com/science/article/pii/S0026049523003505
